Ubs Group Ag Cardiff Oncology, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 633,000 shares of CRDF stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

633,000

Previous 633,000 -0.0%

Holding current value

$1.59 Million

Previous $1.41 Million 20.28%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.05 - $2.77 $13,527 - $18,279	6,599 Added 15.73%	48,564 $129,000
Q2 2024 Aug 13, 2024	BUY	$2.22 - $5.89 $86,586 - $229,727	39,003 Added 1316.78%	41,965 $93,000
Q1 2024 May 13, 2024	SELL	$1.46 - $5.91 $573 - $2,322	-393 Reduced 11.71%	2,962 $15,000
Q4 2023 Feb 09, 2024	BUY	$0.96 - $1.55 $3,160 - $5,102	3,292 Added 5225.4%	3,355 $4,000
Q3 2023 Nov 09, 2023	SELL	$1.38 - $2.18 $5,176 - $8,177	-3,751 Reduced 98.35%	63 $0
Q2 2023 Aug 11, 2023	SELL	$1.37 - $1.95 $16,270 - $23,158	-11,876 Reduced 75.69%	3,814 $5,000
Q1 2023 May 12, 2023	BUY	$1.45 - $2.09 $14,507 - $20,910	10,005 Added 175.99%	15,690 $25,000
Q4 2022 Feb 08, 2023	SELL	$1.22 - $1.66 $3,367 - $4,581	-2,760 Reduced 32.68%	5,685 $7,000
Q3 2022 Nov 10, 2022	BUY	$1.54 - $3.21 $12,940 - $26,973	8,403 Added 20007.14%	8,445 $13,000
Q2 2022 Aug 10, 2022	SELL	$1.17 - $2.61 $8,122 - $18,118	-6,942 Reduced 99.4%	42 $0
Q1 2022 May 16, 2022	SELL	$2.11 - $7.25 $10,718 - $36,830	-5,080 Reduced 42.11%	6,984 $17,000
Q4 2021 Feb 14, 2022	BUY	$5.18 - $7.24 $45,086 - $63,016	8,704 Added 259.05%	12,064 $72,000
Q3 2021 Nov 15, 2021	BUY	$5.01 - $7.58 $16,833 - $25,468	3,360 New	3,360 $22,000
Q1 2021 May 12, 2021	SELL	$9.1 - $19.57 $5,769 - $12,407	-634 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$12.02 - $24.71 $37,802 - $77,712	-3,145 Reduced 83.22%	634 $11,000
Q3 2020 Nov 12, 2020	SELL	$4.25 - $14.19 $3,157 - $10,543	-743 Reduced 16.43%	3,779 $53,000
Q2 2020 Jul 31, 2020	BUY	$0.78 - $5.1 $3,527 - $23,062	4,522 New	4,522 $23,000

Others Institutions Holding CRDF

# of Institutions

Shares Held

12.3M

Call Options Held

813K

Put Options Held

91.1K

View Full List

About Cardiff Oncology, Inc.

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $109M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

More about CRDF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account